ЗначениеQ4, 24TTMДенежный поток от инвестиционной деятельности27.24 M350.44 MДенежный поток от финансовой деятельности-254.57 M-969.59 MСвободный денежный поток333.51 M884.27 M
Exelixis Inc
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.